Pharmaceuticals and Healthcare Reports Japan Dyslipidemia Market

Clique para ler

Pharmaceuticals and Healthcare Reports
Japan Dyslipidemia Market

Publicado no 26 April 2017 e em "Saúde & Fitness, Saúde & Fitness", idioma — English. 3 páginas.

Descrição da publicação:

The launch of the proprotein convertase subtilisin/kexin type 9 (PCSK9) biologics and the cholesteryl ester transfer protein (CETP) inhibitors will reshape the sales landscape of the dyslipidemia market moving forward. Mais

Mostrar Tags

Etiquetas: japan dyslipidemia market analysis

Ler Baixar

Assine GRÁTIS

Outras publicação de "Pharmaceuticals and Healthcare Reports"

Gorlin Syndrome (Basal Cell Nevus Syndrome) Market

Gorlin Syndrome (Basal Cell Nevus Syndrome) Market

Coronary Artery Disease (CAD) (Ischemic Heart Dise

Coronary Artery Disease (CAD) (Ischemic Heart Dise

Chemotherapy Induced Neutropenia Market Size, Shar

Chemotherapy Induced Neutropenia Market Size, Shar

Autism Market Size, Share, Growth, Trends, Analysi

Autism Market Size, Share, Growth, Trends, Analysi

Ver todas as publicações